Hebei Changshan Biochem Pharma Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Hebei Changshan Biochem Pharma cash flow conversion efficiency. Based on the latest financial reports, Hebei Changshan Biochem Pharma (300255) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.86 Million ≈ $-4.52 Million USD) by net assets (CN¥1.48 Billion ≈ $216.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hebei Changshan Biochem Pharma (2008–2024)

Cash flow conversion efficiency of Hebei Changshan Biochem Pharma from 2008 to 2024. This chart illustrates how Hebei Changshan Biochem Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hebei Changshan Biochem Pharma stock price for real-time trading data and today's change.

Hebei Changshan Biochem Pharma Cash Flow Conversion Ratio Explained

Hebei Changshan Biochem Pharma cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hebei Changshan Biochem Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hebei Changshan Biochem Pharma ranked by their cash flow conversion efficiency. Also see market cap of Hebei Changshan Biochem Pharma for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zealand Pharma A/S CO:ZEAL	-0.070x
Dana Inc NYSE:DAN	0.441x
PT Trimegah Bangun Persada Tbk JK:NCKL	0.075x
Xiamen Xiangyu Co Ltd SHG:600057	0.264x
CN LGY.PWR.GR.UNSP.ADR/10 F:6WX0	N/A
Koninklijke BAM Groep NV AS:BAMNB	-0.153x
Privia Health Group Inc NASDAQ:PRVA	0.000x
Livzon Pharmaceutical Group Inc SHE:000513	0.040x

Annual Cash Flow Conversion Efficiency for Hebei Changshan Biochem Pharma (2008–2024)

The table below shows the annual cash flow conversion efficiency of Hebei Changshan Biochem Pharma from 2008 to 2024. Review how much free cash does Hebei Changshan Biochem Pharma generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.54 Billion ≈ $224.73 Million	CN¥56.22 Million ≈ $8.23 Million	0.037x	+95.34%
2023-12-31	CN¥1.80 Billion ≈ $263.35 Million	CN¥33.73 Million ≈ $4.94 Million	0.019x	+1731.13%
2022-12-31	CN¥3.05 Billion ≈ $446.90 Million	CN¥3.13 Million ≈ $457.36K	0.001x	+9.49%
2021-12-31	CN¥3.07 Billion ≈ $449.55 Million	CN¥2.87 Million ≈ $420.19K	0.001x	+101.45%
2020-12-31	CN¥2.85 Billion ≈ $417.52 Million	CN¥-183.58 Million ≈ $-26.86 Million	-0.064x	-201.33%
2019-12-31	CN¥2.72 Billion ≈ $398.35 Million	CN¥-58.13 Million ≈ $-8.51 Million	-0.021x	-118.40%
2018-12-31	CN¥2.52 Billion ≈ $369.20 Million	CN¥292.81 Million ≈ $42.85 Million	0.116x	+74.17%
2017-12-31	CN¥2.44 Billion ≈ $356.37 Million	CN¥162.28 Million ≈ $23.75 Million	0.067x	-11.29%
2016-12-31	CN¥2.29 Billion ≈ $335.01 Million	CN¥171.96 Million ≈ $25.16 Million	0.075x	+409.43%
2015-12-31	CN¥1.57 Billion ≈ $229.92 Million	CN¥-38.14 Million ≈ $-5.58 Million	-0.024x	+59.24%
2014-12-31	CN¥1.43 Billion ≈ $208.80 Million	CN¥-84.97 Million ≈ $-12.43 Million	-0.060x	-402.15%
2013-12-31	CN¥1.29 Billion ≈ $188.11 Million	CN¥-15.24 Million ≈ $-2.23 Million	-0.012x	+81.10%
2012-12-31	CN¥1.13 Billion ≈ $164.72 Million	CN¥-70.62 Million ≈ $-10.33 Million	-0.063x	-463.52%
2011-12-31	CN¥987.45 Million ≈ $144.49 Million	CN¥17.04 Million ≈ $2.49 Million	0.017x	-87.05%
2010-12-31	CN¥219.39 Million ≈ $32.10 Million	CN¥29.25 Million ≈ $4.28 Million	0.133x	-12.34%
2009-12-31	CN¥159.19 Million ≈ $23.30 Million	CN¥24.21 Million ≈ $3.54 Million	0.152x	+146.09%
2008-12-31	CN¥93.43 Million ≈ $13.67 Million	CN¥-30.83 Million ≈ $-4.51 Million	-0.330x	--

About Hebei Changshan Biochem Pharma

SHE:300255 China Biotechnology

Market Cap

$2.58 Billion

CN¥17.64 Billion CNY

Market Cap Rank

#5176 Global

#834 in China

Share Price

CN¥19.19

Change (1 day)

-1.08%

52-Week Range

CN¥18.73 - CN¥68.32

All Time High

CN¥69.80